AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2017
Dec 12, 2017
35086_dirs_2017-12-12_04fb851b-f91b-477a-b646-1e259f6dec20.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-12-11
Reporting Person: Russell Richard E. (President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-11 | Common Stock | A | 40000 | $0.00 | Acquired | 40000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-11 | Employee Stock option (Right to Buy) | $6.05 | A | 775000 | Acquired | 2027-12-10 | Common Stock (775000) | Direct |
Footnotes
F1: Represents shares of the Issuer's Common Stock underlying a time-based restricted stock unit award ("RSU"). The shares subject to this RSU will vest in four (4) equal annual installments commencing on the one-year anniversary of December 11, 2017, provided the Reporting Person has provided continuous service to the Issuer through the vesting date.
F2: This option vested as to 25% of the shares on December 11, 2018 and then in quarterly installments over 3 years thereafter.
More from Minerva Neurosciences, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17